To verify whether these cells are cross-resistant to those agents, we have well characterized Pgp, MRP1, MRP3 and BCRP expression and activity, which have been shown involving in the chemoresistance of AML treatment [4,22], in K562, HL60 and their derivation cell lines. The gene discussed is PGP; the disease is acute myeloid leukemia.